Science Explorer Back to mapMap
Discussion
Company · Cambridge · United Kingdom

F-star (United Kingdom)

f-star.comROR OpenAlex
Research works
35
▼ 69% vs 2018-21
Citations
413
11.8 per fractional work
Top-10% rate
13.2%
all institutions 10.0%
Open access
30%
world 40%
International
19%
world 18%
F-star (United Kingdom)

Not ranked overall: F-star (United Kingdom) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does F-star (United Kingdom) work in?

In all years, 63% of research at F-star (United Kingdom) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (62%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (9%). It does 2.2× the world's share of Health Sciences.

Health Sciences: 22 fractional works · 62.9% of its workMedicine: 22 fractional works · 61.6% of its workOncology: 10 fractional works · 29.8% of its workRadiology, Nuclear Medicine and Imaging: 10 fractional works · 27.1% of its workGenetics: 1 fractional works · 1.9% of its workImmunology and Allergy: 0 fractional works · 0.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.5% of its workHealth Professions: 0 fractional works · 1.4% of its workEmergency Medical Services: 0 fractional works · 0.9% of its workGeneral Health Professions: 0 fractional works · 0.4% of its workLife Sciences: 10 fractional works · 29.2% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 18.0% of its workMolecular Biology: 4 fractional works · 10.8% of its workBiotechnology: 1 fractional works · 3.0% of its workCancer Research: 1 fractional works · 2.8% of its workCell Biology: 0 fractional works · 0.9% of its workPhysiology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 3 fractional works · 9.2% of its workImmunology: 3 fractional works · 9.1% of its workAgricultural and Biological Sciences: 1 fractional works · 2.1% of its workAnimal Science and Zoology: 1 fractional works · 1.7% of its workFood Science: 0 fractional works · 0.3% of its workPhysical Sciences: 2 fractional works · 6.2% of its workComputer Science: 1 fractional works · 2.3% of its workArtificial Intelligence: 0 fractional works · 0.9% of its workHardware and Architecture: 0 fractional works · 0.6% of its workComputer Networks and Communications: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 1 fractional works · 2.1% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.9% of its workBiomedical Engineering: 0 fractional works · 0.5% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workAerospace Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnvironmental Science: 0 fractional works · 0.7% of its workEnvironmental Engineering: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.6% of its workBiomaterials: 0 fractional works · 0.6% of its workChemistry: 0 fractional works · 0.3% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.0% of its workSocial Sciences: 1 fractional works · 1.7% of its workDecision Sciences: 0 fractional works · 1.4% of its workManagement Science and Operations Research: 0 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workALL ITS WORKF-star (UnitedKingdom)35fractional works, all years
Life Sciences29%Physical Sciences6%Health Sciences63%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine2261.6%
    2. Health Professions01.4%
    1. Biochemistry, Genetics and Molecular Biology618.0%
    2. Immunology and Microbiology39.2%
    3. Agricultural and Biological Sciences12.1%
    1. Computer Science12.3%
    2. Engineering12.1%
    3. Environmental Science00.7%
    4. Materials Science00.6%
    5. Chemistry00.3%
    6. Earth and Planetary Sciences00.2%
    7. Energy00.0%
    1. Decision Sciences01.4%
    2. Social Sciences00.2%
    3. Economics, Econometrics and Finance00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.10× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.42× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 6.15× its world share, 0 worksImmunology and Micro…Chemistry: 1.11× its world share, 0 worksChemistryComputer Science: 0.81× its world share, 0 worksComputer ScienceEnergy: 0.20× its world share, 0 worksEnergyEngineering: 0.49× its world share, 0 worksEngineeringEnvironmental Science: 0.22× its world share, 0 worksEnvironmental ScienceMedicine: 3.31× its world share, 4 worksMedicineEconomics, Econometrics and Finance: 0.27× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.2×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Immunology and Microbiology6.15×0 works
  2. Medicine3.31×4 works
  3. Biochemistry, Genetics and Molecular Biology1.42×0 works
  4. Chemistry1.11×0 works
  5. Agricultural and Biological Sciences1.10×0 works
  6. Computer Science0.81×0 works
  7. Engineering0.49×0 works
  8. Economics, Econometrics and Finance0.27×0 works
  9. Environmental Science0.22×0 works
  10. Energy0.20×0 works

Who are the top researchers at F-star (United Kingdom)?

Ranked on the quality score, Neil Brewis, Michelle Morrow and Mateusz M. Wydro lead among researchers whose main affiliation is F-star (United Kingdom).

  1. 1 Neil Brewis United Kingdom · #529,766 worldwide 1.9k citations · 127 works
  2. 2 Michelle Morrow United Kingdom · #574,154 worldwide 4k citations · 183 works
  3. 3 Mateusz M. Wydro United Kingdom · #830,439 worldwide 1.6k citations · 33 works
  4. 4 Edmund Poon United Kingdom · #1,094,098 worldwide 2.7k citations · 88 works
  5. 5 Claire S. Reader United Kingdom · #1,206,102 worldwide 311 citations · 26 works
  6. 6 Daniel Gliddon United Kingdom · #1,527,113 worldwide 494 citations · 40 works
  7. 7 Mihriban Tuna United Kingdom · #1,823,821 worldwide 385 citations · 32 works
  8. 8 Katy L. Everett United Kingdom · #2,178,948 worldwide 868 citations · 27 works
  9. 9 Sylwia Marshall United Kingdom · #2,256,451 worldwide 293 citations · 33 works
  10. 10 Katarzyna Kmiecik United Kingdom · #3,024,121 worldwide 279 citations · 23 works
All ranked researchers at F-star (United Kingdom)

What are the most cited papers from F-star (United Kingdom)?

The most cited paper from F-star (United Kingdom) is "FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity" (Matthew Kraman, Mustapha Faroudi, Natalie L. Allen et al., 2020), with 113 citations. Next come "Systemic evaluation: a participative, multi-method approach" (71) and "FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Exhibits Low Toxicity and Antitumor Activity in Colorectal Cancer Models" (67).

Most cited papers
#PaperReleasedCitations
1 FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity Matthew Kraman, Mustapha Faroudi, Natalie L. Allen et al. · Clinical Cancer Research 16 Apr 2020 113
2 Systemic evaluation: a participative, multi-method approach Alan Boyd, T. Geerling, W. J. Gregory et al. · Journal of the Operational Research Society 6 Sep 2006 71
3 FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Exhibits Low Toxicity and Antitumor Activity in Colorectal Cancer Models Matthew A. Lakins, Alexander Koers, Raffaella Giambalvo et al. · Clinical Cancer Research 28 Apr 2020 67
4 CD137/OX40 Bispecific Antibody Induces Potent Antitumor Activity that Is Dependent on Target Coengagement Miguel A. Gaspar, John Pravin, Leonor Nunes Rodrigues et al. · Cancer Immunology Research 9 Apr 2020 57
5 A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 Resistance Timothy Anthony Yap et al. · Clinical Cancer Research Open access 7 Nov 2022 53
All 33 most cited papers, with filters and sorting

Which keywords describe research at F-star (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Tumor Microenvironment, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Immune Checkpoint Blockade and PD-1 and PD-L1.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Glycosylation8▲ 107×3 topics
  2. Tumor Microenvironment8▲ 63×6 topics
  3. Monoclonal Antibodies7▲ 139×3 topics
  4. Therapeutic Antibodies7▲ 155×2 topics
  5. Antibody Engineering6▲ 182×1 topic
  6. Fc Receptors6▲ 182×1 topic
  7. Immune Checkpoint Blockade6▲ 309×1 topic
  8. PD-1 and PD-L16▲ 309×1 topic
  9. Cancer Immunotherapy5▲ 96×2 topics
  10. Immunotherapy4▲ 18×5 topics
  11. PET Imaging3▲ 42×2 topics
  12. Tumor Regression3▲ 103×2 topics
  13. Radiopharmaceuticals3▲ 202×1 topic
  14. Targeted Therapy3▲ 37×1 topic
  15. Antigen Presentation2▲ 68×2 topics
  16. CAR T Cells2▲ 160×1 topic
  17. Chimeric Antigen Receptor2▲ 160×1 topic
  18. Innate Immunity2▲ 19×2 topics
  19. Cancer2▲ 4.7×3 topics
  20. Dendritic Cells2▲ 57×1 topic
  21. Immunity2▲ 19×1 topic
  22. Glycans2▲ 62×1 topic
  23. Immune System2▲ 15×1 topic
  24. Monoclonal Antibody1▲ 49×2 topics
  25. Chemotherapy1▲ 4.4×2 topics
  26. Gene Therapy1▲ 11×2 topics
  27. Breast Cancer1▲ 11×1 topic
  28. HER21▲ 97×1 topic
  29. HIF-11▲ 40×1 topic
  30. Warburg Effect1▲ 40×1 topic

Which research topics does F-star (United Kingdom) publish most on?

By volume in 2022-now: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Radiopharmaceutical Chemistry and Applications and Monoclonal and Polyclonal Antibodies Research.

Cancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksCAR-T cell therapy research: 1 fractional worksRadiopharmaceutical Chemistry and Applications: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksIndustrial Vision Systems and Defect Detection: 0 fractional worksCancer Research and Trea…0Cancer Research and Treatments: 0 fractional worksCancer Cells and Metastasis: 0 fractional worksMeat and Animal Product Quality: 0 fractional worksCancer-related Molecular Pathways: 0 fractional worksNeuroblastoma Research and Treatments: 0 fractional works
OncologyRadiology, Nuclear Medicine and ImagingIndustrial and Manufacturing EngineeringBiotechnology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 1 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Industrial Vision Systems and Defect Detection Industrial and Manufacturing Engineering 0 works
  6. 6 Cancer Research and Treatments Biotechnology 0 works
  7. 7 Cancer Cells and Metastasis Oncology 0 works
  8. 8 Meat and Animal Product Quality Animal Science and Zoology 0 works
  9. 9 Cancer-related Molecular Pathways Oncology 0 works
  10. 10 Neuroblastoma Research and Treatments Neurology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.8%not open70.2%

World: 40% of research is openly available.

with international co-authors19.3%domestic only80.7%

World: 18% is written across borders.

How has F-star (United Kingdom)'s research output changed?

Output in 2022-2025 was 69% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is F-star (United Kingdom) as a percentage of every work published that year, 0.000039% in 2024.

still counting0.00010%0.00020%F-star (United Kingdom)0.000025% in 202520102020

Fractional works of F-star (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about F-star (United Kingdom). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.